Requirement for innate immunity and CD90 NK1.1 lymphocytes to treat established melanoma with chemo-immunotherapy.
Cancer Immunology Research.
Times cited: 4
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease.
Journal of Investigative Dermatology.
Times cited: 14